Can bladder preservation therapy come to the center stage?. (23rd November 2017)

• Record Type: Journal Article
• Authors: Inamoto, Teruo; Ibuki, Naokazu; Komura, Kazumasa; Juri, Hiroshi; Yamamoto, Kiyohito; Yamamoto, Kazuhiro; Fujita, Kazutoshi; Nonomura, Norio; Narumi, Yoshifumi; Azuma, Haruhito
• Is Part Of: International journal of urology. Volume 25:Number 2(2018)
• Page Start: 134
• Page End: 140
• Publication Date: 2017-11-23
• Subjects: bladder preservation -- muscle‐invasive bladder cancer -- prognosis; Urology -- Periodicals; Genitourinary organs -- Periodicals; Urologic Diseases -- Periodicals; 616.6005
• DOI: 10.1111/iju.13495
• Languages: English
• ISSNs: 0919-8172

Abstract

Abstract: Decision‐making in urological cancer care requires a multidisciplinary approach for refinement, but its impact on urothelial carcinoma of the bladder has not been fully addressed for the past three decades, except for the latest immunological checkpoint inhibitor approved by the U.S. Food and Drug Administration for metastatic muscle‐invasive bladder cancer that is resistant to platinum‐based chemotherapy. For the time being, radical cystectomy is the gold standard of curative therapy for muscle‐invasive bladder cancer. Trimodal therapy that combines chemotherapy for the purpose of radiation sensitization, external beam radiotherapy and transurethral resection of bladder tumor has emerged as a potential alternative treatment option that preserves the bladder. In lack of randomized studies for bladder preservation therapy compared with surgery, the principles of management of urothelial carcinoma of the bladder have evolved in recent times, with an emphasis on bladder preservation. A number of bladder preservation techniques are available to the surgeon; however, appropriately selected patients with muscle‐invasive bladder cancer should be offered the opportunity to discuss various treatment options, including organ‐sparing trimodal therapy. The aim of the present study was to compare the primary outcomes of the available treatment methods and identify the sources of variance among studies. A review of various bladder preservation techniques in vogue for the management of urothelial carcinoma of the bladder is discussed.